3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Unknown
1
Sponsor Class
OTHER
4
NETWORK
1
Study Type
Interventional
1
Sponsor
Conditions
Wounds and Injuries
1
Trauma, Nervous System
1
Stress Disorders, Post-Traumatic
1
Neoplasms
1
Depression
1
Interventions
Cisplatin
24
Radiotherapy
18
Carboplatin
18
Paclitaxel
17
Vincristine
15
Cyclophosphamide
14
Etoposide
13
Filgrastim
12
Doxorubicin
12
Gemcitabine
11
Temozolomide
10
Cytarabine
9
Topotecan
8
Docetaxel
8
Methotrexate
7
Irinotecan
7
Granulocyte Colony-Stimulating Factor
7
Dexamethasone
7
Taxes
6
Radiation
6
Peripheral Blood Stem Cell Transplantation
6
Radiotherapy, Conformal
5
Oxaliplatin
5
Melphalan
5
Fenretinide
5
Chemotherapy, Adjuvant
5
Capecitabine
5
etoposide phosphate
4
Trastuzumab
4
Platinum
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
NETWORK
×
Psilocybin
×
Clear all
NCT05042466
2022-11-16
NWTTPS
NWTraumatherapies
Phase 1
Unknown
30 enrolled